U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that the x-ray was discovered purely by accident? When German physicist Wilhelm Konrad von Roentgen was experimenting with cathode rays in 1895, he put an activated Crookes tube in a book and went out to lunch. When he returned, he discovered that a key that had also been placed in the book showed up as an image on the developed film!

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/329 - Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein nitrogen is attached indirectly to the
No. of applications: 137
Last issue date: 02/09/2012


1        
Application No.Application TitleIssue Date
20120035187ANTI-NEURODEGENERATIVE DISEASE AGENT
The present invention has an object to provide a novel agent for anti-neurodegenerative diseases and solves the object by providing an agent for anti-neurodegenerative diseases containing, as an effective ingredient, the compound(s) represented by the following General ...
02/09/2012
20120022264METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION
Process for preparing 2,2-difluoroethylamine derivatives, wherein compounds of the general formula (IV) are hydrogenated to the corresponding 2,2-difluoroethylamine derivatives of the general formula (III), where the A, R1 and R2 radicals are each ...
01/26/2012
20120012830MATERIAL FOR ORGANIC PHOTOELECTRIC DEVICE, AND ORGANIC PHOTOELECTRIC DEVICE THEREBY
A material for an organic photoelectric device, the material including a compound represented by the following Chemical Formula 1:

    • 01/19/2012
20120004262PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE
The present invention relates to phenylcyclopropylamine derivatives. In particular, pharmaceutical compositions comprising phenylcyclopropylamine derivatives are provided. The compounds of this invention can, inter alia, be used for the treatment and the prevention of c...
01/05/2012
20110306770Process for preparing 2-2-difluoroethylamine derivatives by alkylation with 2-2-difluoroethyl-1-haloethanes
Process for preparing 2,2-difluorethylamine derivatives of the general formula (III)

in which A is an optionally substituted heterocycle as described in the description, by reacting a 2,2-difluoroethyl-1-halo...

12/15/2011
20110245504SYNTHESIS OF 9-(ARYLALKYL)-1,2,3,4-TETRAHYDRO-y-CARBOLINE AND ANALOGUES AND INTERMEDIATES
The present invention pertains generally to methods of preparing certain 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline compounds and their analogues, and especially to methods of preparing dimebon. The present invention also pertains to methods of preparing certain inte...
10/06/2011
20110237627METHODS OF SYNTHESIZING ANATABINE
Anatabine is obtained by reacting benzophenoneimine with 3-aminomethyl pyridine to form benzylhydrylidene-pyridin-3-yl-methyl-amine. The benzylhydrylidene-pyridin-3-yl-methyl-amine is treated with a non-nucleophilic base and a dielectrophile, such as cis-1,4-dichloro-2-...
09/29/2011
20110230517CALCIUM RECEPTOR MODULATING AGENTS
The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compound...
09/22/2011
20110166190METHODS OF TREATING MAMMALS WITH EUSTACHIAN TUBE DYSFUNCTIONS
The invention relates to methods of medically treating mammals with Eustachian tube dysfunctions, such as Ménière's disease, vertigo, Otitis Media (including Otitis Media with Effusion (OME), Acute Otitis Media (AOM) and Aerotitis Media (AM)) as well as other disorder...
07/07/2011
20110152525PROCESS FOR PREPARING AMINES FROM ALCOHOLS AND AMMONIA
The present invention provides novel ruthenium based catalysts, and a process for preparing amines, by reacting a primary alcohol and ammonia in the presence of such catalysts, to generate the amine and water. According to the process of the invention, primary alcohols ...
06/23/2011
20110098429Catalyst Compounds and Use Thereof
This invention relates to Group 4 catalyst compounds containing di-anionic tridentate nitrogen/oxygen based ligands. The catalyst compounds are useful, with or without activators, to polymerize olefins, particularly a-olefins, or other unsaturated monomers. Systems and ...
04/28/2011
20110065705Compositions and Methods of Treating Cell Proliferation Disorders
The invention relates to compounds and methods for treating cell proliferation disorders....
03/17/2011
20110046146Phosphodiesterase 4 inhibitors
PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I:
wherein R1, R2, R3and R4 are as defined herein. ...
02/24/2011
20100298572METHODS OF PREPARING SECONDARY CARBINAMINE COMPOUNDS WITH BORONIC ACIDS
The present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds of the formula Ia, formula Ib or formula IV from aldehydes of the formula II and boronic acids of the...
11/25/2010
20100274021METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION
Process for preparing 2,2-difluoroethylamine derivatives, wherein compounds of the general formula (IV) are hydrogenated to the corresponding 2,2-difluoroethylamine derivatives of the general formula (III), where the A radical is as defined in the description:

10/28/2010
20100260750Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
Novel serotonin reuptake inhibitor compounds which are designed to exert serotonin uptake inhibitory activity in the peripheral system while being devoid of CNS activity, and a process of preparing same are disclosed. Further disclosed are pharmaceutical compositions co...
10/14/2010
20100222593METHOD FOR PRODUCING 2,2-DIFLUOROETHYLAMINE DERIVATIVE BY AMIDE HYDROGENATION
Process for preparing 2,2-difluoroethylamine derivatives, wherein compounds of the general formula (IV) are reduced to the corresponding 2,2-difluoroethylamine derivatives of the general formula (III), where the A radical is as defined in the description:

09/02/2010

20100213826Material for organic photoelectric device, and organic photoelectric device thereby
A material for an organic photoelectric device, the material including a compound represented by the following Chemical Formula 1:

    • 08/26/2010
20100202965ANNULUS FIBROSUS DETECTION IN INTERVERTEBRAL DISCS USING MOLECULAR IMAGING AGENTS
The present invention relates to methods for imaging annulus fibrosus tissue and a quantitative measurement of its local concentration in a sample using an agent comprising the compound of Formula I, a 13C or 2H enriched compound of Formula I, an <...
08/12/2010
20100197930PROCESS FOR PRODUCING TOLUIDINE COMPOUND
Because fluazinam is excellent as an active ingredient of pesticides and highly useful, it is desired to produce it efficiently in a proper form with simple operations at low cost in an environmentally friendly manner. The desired product is obtained in good yields with...
08/05/2010
20100184741GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein R1a, R1b, R1c, R1d, ...
07/22/2010
20100179199Ethanamine Compounds and Methods of Using the Same 545
The present invention is directed to ethanamine compounds, pharmaceutical compositions comprising the same, and methods of treating depression by administering the ethanamine compound....
07/15/2010
20100174090METHODS OF PREPARING PRIMARY, SECONDARY AND TERTIARY CARBINAMINE COMPOUNDS IN THE PRESENCE OF AMMONIA
The present application relates to novel methods for the preparation of primary, secondary and tertiary carbinamine compounds, particularly the preparation of compounds of formulae I, IV and VI, from a carbonyl compound of formula II in the presence of ammonia or an amm...
07/08/2010
20100158818ANTIMICROBIAL N-CHLORINATED COMPOSITIONS
The present application relates to N-chlorinated cationic compounds of Formula I

or a salt thereof, and associated compositions and methods of use as antimicrobial agents....

06/24/2010
20100160390COMPOUNDS CAPABLE OF ACTIVATING CHOLINERGIC RECEPTORS
Compounds incorporating aryl substituted olefinic amine are provided. Representative compounds are (4E)-N-methyl-5-(3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-pyrimidinyl)-4-penten-2-amine, (4E)-N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine, (4E)-N-methyl-5-(6-...
06/24/2010
20100133519ARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES
There is provided conductive organic arylamine compounds. The compounds may be prepared as films and such films may be used as a hole transporting layer, an emissive layer or an electron transporting layer in organic light emitting devices....
06/03/2010
20100120872ORGANIC COMPOUNDS AND THEIR USES
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases....
05/13/2010
20100121054PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE
The present invention provides a process that enables a substituted methylamine compound which is useful as an intermediate for the production of agricultural chemicals and medicines, to be produced easily, with good yield, and at low cost, and also provides a productio...
05/13/2010
20100099682ACETYLENE DERIVATIVES
The invention provides compounds of formula (I)

wherein

  • R1 represents hydrogen or alkyl;
  • 04/22/2010
20100069447BENZAMIDE DERIVATIVES AND USES RELATED THERETO
Benzamide derivatives of formulae I and II, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof, and pharmaceutical compositions comprising the same, are described and have therapeutic utility, particularly in the treatment of diabetes, ...
03/18/2010
20100036119FLUORINATING REAGENTS AND THEIR PREPARATION
The present invention relates to α,α-difluoroamines, fluorinating reagents comprising α,α-difluoroamines and also processes for preparing α,α-difluoroamines and fluorinating reagents comprising α,α-difluoroamines....
02/11/2010
20100029952Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems
Fluorophores derived from photoactivatable azide-pi-acceptor fluorogens or from a thermal reaction of an azide-pi-acceptor fluorogen with an alkene or alkyne are disclosed. Fluorophores derived from a thermal reaction of an alkyne-pi-acceptor fluorogen with an azide are...
02/04/2010
20100022394PRODUCTS FOR THE TREATMENT OF THE IRON CHLOROSIS
The present invention consists on the synthesis of new products for the treatment of the iron chlorosis. These products may have improved properties regarding the currently known treatments. The new products are non-symmetrical ethylene diamino hidroxyphenyl acetic acid...
01/28/2010
20100022726Pyridyldiamido Transition Metal Complexes, Production And Use Thereof
Pyridyldiamido transition metal complexes are disclosed for use in alkene polymerization. The ligands are tridentate with an NNN configuration. The general formula is: (I)

...

01/28/2010
20100001635Novel organic electroluminescent compounds and organic electroluminescent device using the same
The present invention relates to novel organic electroluminescent compounds, and organic electroluminescent devices employing the same in an electroluminescent layer. Specifically, the organic electroluminescent compounds according to the invention are characterized in ...
01/07/2010
20090314990NOVEL TRIPHENYLAMINE DERIVATIVES USEFUL AS FLUOROPHORES IN BIOLOGY, IN PARTICULAR FOR TWO-PHOTON MICROSCOPY
Triphenylamine derivatives useful as fluorophores in biology, in particular for two-photon microscopy; and

compositions comprising these derivatives, to the use of these compositions and of the derivatives themselves for labelling biologica...

12/24/2009
20090286775Bicyclic Derivatives as P38 Kinase Inhibitors
New bicyclic derivatives of formula (I), wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as p38 kinase inhibitors.

...

11/19/2009
20090286275Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe
A two-photon probe for real-time monitoring of intracellular free zinc ions is provided. The two-photon probe is represented by Formula 1:

wherein R is H or OCH3. The two-photon probe has high sele...

11/19/2009
20090281325METHOD FOR SELECTIVELY PRODUCING PRIMARY AMINE COMPOUND
Disclosed is a method for producing a primary amine compound represented by the formula (3):

wherein, Ar is as defined below , which is characterized in that a halogen compound represented by the formula (1):...

11/12/2009
20090275556Aryl sulfonamides useful as inhibitors of chemokine receptor activity
The present invention provides compounds of general formula I:

or a pharmaceutically acceptable salt thereof, wherein R1, X, Z, R2, X1, Ar, n, R3 and R4 ...

11/05/2009
1        
 
Sign InRegister
Username  
Password   
forgot password?